HLA Demographics Study in Adults With Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Bach, MD
GentiBio, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco
San Francisco, California, United States
Stephen Gitelman, MDRecruiting - University of Florida- Gainesville
Gainesville, Florida, United States
Michael Haller, MDRecruiting - Joslin Diabetes Center
Boston, Massachusetts, United States
Jason Gaglia, MDRecruiting - Icahn School of Medicine at Mount Sinai
New York, New York, United States
Carol Levy, MDRecruiting - University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Klara Klein, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jun 2025
- Primary completion
- 30 Jan 2027
- Completion
- 31 Mar 2027
- Last update posted
- 6 May 2026
- Registered enrollment
- 200
- Registry id
- NCT06860516
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.